Nuwellis (NUWE) Preferred Stock Liabilities (2016 - 2026)
Nuwellis' (NUWE) quarterly Preferred Stock Liabilities came in at $10000.0 in Q2 2026, up 100.0% on a YoY basis from $5000.0 in Q2 2025, and up 25.0% quarter-over-quarter from $8000.0 in Q1 2026.
Analysis
Nuwellis (NUWE) Preferred Stock Liabilities (2016 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Preferred Stock Liabilities for 5 consecutive years, with $10000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Preferred Stock Liabilities rose 100.0% year-over-year to $10000.0; the trailing twelve-month figure through Jun 2026 stood at $10000.0 (up 100.0% YoY), and the FY2025 full-year result was $6000.0, up 200.0% from the prior year.
- Preferred Stock Liabilities grew to $10000.0 in Q2 2026 per NUWE's latest filing, from $8000.0 in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $221000.0 in Q4 2023 and bottomed at $2000.0 in Q1 2024.
- Historically, Preferred Stock Liabilities has averaged $24363.6 across 4 years, with a median of $5000.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Preferred Stock Liabilities tumbled 99.1% in 2024, then soared 200.0% in 2025.
- Over 4 years, Preferred Stock Liabilities stood at $221000.0 in 2023, then sank by 99.1% to $2000.0 in 2024, then jumped by 200.0% to $6000.0 in 2025, then surged by 66.67% to $10000.0 in 2026.
- According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $10000.0, $8000.0, and $6000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 10,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 221,000.00 |
| Dec 31, 2016 | 485,000.00 |